Xavier Warling

1.7k citations
22 papers · 1.3k · 3 hit papers · h-index 9

Impact in

  • Nephrology top 1%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
    • Parathyroid Disorders and Treatments
    • Dialysis and Renal Disease Management
    • Diabetes Treatment and Management

Papers in

    • Parathyroid Disorders and Treatments 6
    • Dialysis and Renal Disease Management 3
    • Chronic Kidney Disease and Diabetes 2
    • Renal Diseases and Glomerulopathies 2
    • Blood Pressure and Hypertension Studies 4

Xavier Warling

21 papers receiving 1.3k citations

Xavier Warling's Hit Papers

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 · 185 citations
1850+2+4Years since publication100200300400500

Peers

Xavier Warling
Comparison fields: 5 of 79
  • Nephrology 598
  • Endocrinology, Diabetes and Metabolism 215
  • Cardiology and Cardiovascular Medicine 219
  • Hematology 102
  • Nutrition and Dietetics 121
Replace Rupal C. Mehta with:
Rupal C. Mehta United States
Konstantinos C. Siamopoulos Greece
Serge H. Cournoyer Canada
Nelson P. Kopyt United States
Femke Waanders Netherlands
Nadia Rubis Italy
E. Ishimura Japan
Satoru Kuriyama Japan
Leyi Gu China
Claude M. Galphin United States
Xavier Warling relative to Rupal C. Mehta United States Rupal C. Mehta's profile →
Citations per field
00.5×2×3.3×
Rupal C. Mehta · 1×
Citations per year

Countries citing papers authored by Xavier Warling

Since Specialization
Citations

This map shows the geographic impact of Xavier Warling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Warling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Warling more than expected).

Fields of papers citing papers by Xavier Warling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Warling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Warling. The network helps show where Xavier Warling may publish in the future.

Co-authors

The 25 scholars most cited alongside Xavier Warling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xavier Warling Line = papers co-authored together Xavier Warling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hit paper breakdown →
2019519
2
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Hit paper breakdown →
2023185
3
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Hit paper breakdown →
2023160
4 2014105
5 200299
6 201365
7 201455
8 201948
9 200744
10 20117
11 20107
12 20175
13 20144
14 20133
15 20203
16 20223
17 20132
18
[Does ambulatory blood pressure measurement allow a better definition of arterial hypertension?].
19881
19 20181
20
La mesure ambulatoire de la pression artérielle permet d'améliorer la définition de l'hypertension artérielle
19881

About Xavier Warling

Xavier Warling is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (6 papers), Blood Pressure and Hypertension Studies (4 papers), Dialysis and Renal Disease Management (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Renal Diseases and Glomerulopathies (2 papers), Psychosomatic Disorders and Their Treatments (1 paper), Bone health and osteoporosis research (1 paper) and Malaria Research and Control (1 paper). The work is most often cited by research in Nephrology (598 citations), Endocrinology, Diabetes and Metabolism (215 citations), Cardiology and Cardiovascular Medicine (219 citations), Hematology (102 citations) and Nutrition and Dietetics (121 citations). Xavier Warling has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Jean-Marie Krzesinski, Pierre Delanaye, Etienne Cavalier, Martial Moonen, Robert H. Fagard, Marc Leeman, Maria Van den Enden, Hans Pottel, Olivier Bruyère and Laurent E. Weekers. Their work appears in journals such as Nephrology Dialysis Transplantation, The Lancet, Clinica Chimica Acta, Journal of Renal Nutrition and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact